Article Information
History
- January 12, 2022.
Article Versions
- Version 1 (October 4, 2021 - 17:19).
- Version 2 (December 11, 2021 - 16:01).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Shiro Takamatsu1,
- Junzo Hamanishi1,
- J.B. Brown2,3,
- Ken Yamaguchi1,
- Koji Yamanoi1,
- Kosuke Murakami4,
- Osamu Gotoh5,
- Seiichi Mori5,
- Masaki Mandai1 and
- Noriomi Matsumura4,*
- 1Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University; Kyoto, Japan
- 2Life Science Informatics Research Unit, Department of Molecular Biosciences, Graduate School of Medicine, Kyoto University; Kyoto, Japan
- 3Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University; Kyoto, Japan
- 4Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine; Osaka, Japan
- 5Cancer Precision Medicine Center, Japanese Foundation for Cancer Research; Tokyo, Japan
- ↵*Corresponding author
Noriomi Matsumura, Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine; Osaka, Japan, Address: 377-2, Ohnohigashi, Osaka-Sayama, Osaka, Japan. 589-8511, Tel: +81-72-366-0221, Fax: +81-72-368-3745, E-mail: noriomi{at}med.kindai.ac.jp